Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Therapeutic potential of carbon monoxide in multiple sclerosis.
Fagone P, Mangano K, Coco M, Perciavalle V, Garotta G, Romao CC, Nicoletti F.
Clin Exp Immunol. 2012 Feb;167(2):179-87. doi: 10.1111/j.1365-2249.2011.04491.x. Review.
Related citations
Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?
Meier UC, Giovannoni G, Tzartos JS, Khan G.
Clin Exp Immunol. 2012 Jan;167(1):1-6. doi: 10.1111/j.1365-2249.2011.04446.x. Review.
Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.
Caminero A, Comabella M, Montalban X.
Clin Exp Immunol. 2011 Dec;166(3):338-45. doi: 10.1111/j.1365-2249.2011.04484.x.
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH.
Clin Exp Immunol. 2010 Oct;162(1):1-11. doi: 10.1111/j.1365-2249.2010.04143.x. Review.
99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence.
Ascherio A, Munger KL.
Clin Exp Immunol. 2010 Apr;160(1):120-4. Review.
The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease.
Harnett MM, Melendez AJ, Harnett W.
Clin Exp Immunol. 2010 Mar;159(3):256-67. Epub 2009 Dec 1.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on